Trial Profile
A phase II-b, placebo-controlled trial investigating the efficacy, safety and pharmacokinetics of a subcutaneous etonogestrel implant combined with i.m. [intramuscular] testosterone undecanoate for male contraception
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Feb 2022
Price :
$35
*
At a glance
- Drugs Etonogestrel (Primary) ; Testosterone undecanoate
- Indications Pregnancy
- Focus Therapeutic Use
- Sponsors Organon
- 29 Mar 2008 Results were reported at the 23rd Congress of the European Association of Urology.
- 02 Mar 2007 New trial record.